Followers | 262 |
Posts | 11356 |
Boards Moderated | 1 |
Alias Born | 08/01/2009 |
Thursday, August 13, 2015 10:33:09 AM
Don't you think there is BS built in there somewhere. If I was struggling with money and the CEO of a company and I had money issues and had offers on White Space (the way it was and not completed) I would think seriously of selling White Space and using the money (providing there was any left) to jump start my company.
There should have been increased sales (worldwide)for St. James (the subsidiary).
Mark was talking about franchising Skin Trade.
Working on White Space.
If you have so little money don't you finish one project first when you are this small rather than taking on two projects at the same time.
I try to give Mark the benefit of the doubt but in my minds eye, I would like to see something completed.
Mark told me they would realize revenue from ServeNation (third quarter of 2014 (at the latest). What the hell became of that endeavor.
Is all of this smoke and mirrors.
Go MIKP!
Recent MIKP News
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 11/28/2023 10:00:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/22/2023 06:06:28 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 07:00:35 PM
- Form PREM14C - Preliminary information statements relating to merger or acquisition • Edgar (US Regulatory) • 11/02/2023 04:01:43 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 10/04/2023 04:01:33 PM
- Form 10-12G/A - Registration of securities [Section 12(g)]: [Amend] • Edgar (US Regulatory) • 08/23/2023 08:54:45 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/22/2023 06:10:15 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 01:07:41 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 06/28/2023 01:43:32 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM